Table 2 Univariate and multivariate analyses of prognostic factors for overall survival and progression-free survival
Variable | Univariate | Multivariate | |
|---|---|---|---|
P value | HR (95% CI) | P Value | |
Overall survival | |||
Age (>65 vs. ≤65) | <0.001 | 1.615 (1.116–2.337) | 0.011 |
Gender (male vs. female) | 0.264 | ||
Histology type (NUC vs. UC) | 0.363 | ||
Pathological grade (3 vs. 2) | <0.001 | ||
pT (pT2 or greater vs. pT1) | <0.001 | 2.796 (1.700–4.598) | <0.001 |
pN status (positive vs. negative) | <0.001 | 1.682 (1.141–2.480) | 0.009 |
Smoking history | 0.937 | ||
Hypertension | 0.480 | ||
Diabetes Mellitus | 0.534 | ||
Heart disease | 0.018 | ||
Cerebrovascular disease | 0.032 | ||
ASA grade (3&4 vs. 1&2) | <0.001 | 1.641 (1.113–2.418) | 0.012 |
Hypoalbuminemia | <0.001 | ||
Anemia | <0.001 | ||
Postoperative complications | 0.003 | 1.607 (1.076–2.400) | 0.020 |
PNI (low vs. high) | <0.001 | 1.668 (1.147–2.425) | 0.007 |
PLR (high vs. low) | <0.001 | ||
NLR (high vs. low) | <0.001 | 1.416 (1.094–2.016) | 0.014 |
LMR (low vs. high) | <0.001 | ||
Progression-free survival | |||
Age (>65 vs. ≤65) | <0.001 | ||
Gender (male vs. female) | 0.304 | ||
Histology type (NUC vs. UC) | 0.683 | ||
Pathological grade (3 vs. 2) | <0.001 | ||
pT (pT2 or greater vs. pT1) | <0.001 | 2.560 (1.677–3.906) | <0.001 |
pN status (positive vs. negative) | <0.001 | 1.871 (1.306–2.680) | 0.001 |
Smoking history | 0.952 | ||
Hypertension | 0.604 | ||
Diabetes Mellitus | 0.681 | ||
Heart disease | 0.012 | ||
Cerebrovascular disease | 0.033 | ||
ASA grade (3&4 vs. 1&2) | <0.001 | 1.561 (1.086–2.243) | 0.016 |
Hypoalbuminemia | <0.001 | ||
Anemia | <0.001 | ||
Postoperative complications | 0.004 | ||
PNI (low vs. high) | <0.001 | 1.680 (1.092–2.005) | 0.011 |
PLR (high vs. low) | <0.001 | ||
NLR (high vs. low) | <0.001 | 1.550 (1.140–2.388) | 0.008 |
LMR (low vs. high) | <0.001 | ||